Skip to content

Organon OGN EV / sales

EV / sales at other companies

Pfizer logo
PfizerPFE
3.5×+0.3×
Amgen logo
AmgenAMGN
6.6×+0.1×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
3.6×-1.2×
Biogen logo
BiogenBIIB
+0.8×
AbbVie logo
AbbVieABBV
7.5×+1.0×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
2.1×+0.4×

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Calculated from Organon’s reported figures.

Based on the most recent quarter.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's EV / sales?
Organon (OGN) reported EV / sales of 1.5× in Q1 2026.
How has Organon's EV / sales changed year-over-year?
Organon's EV / sales decreased by 24.9% year-over-year, from 1.9× to 1.5×.
What is the long-term trend for Organon's EV / sales?
Over 4 years (2021 to 2025), Organon's EV / sales has grown at a -11.1% compound annual growth rate (CAGR), from 2.6× to 1.6×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.